
无数据
无数据
无数据
| CAS Number | 42971-09-5 |
| Catalog Number | AG00I8A4(AGN-PC-0RR7ZU) |
| Chemical Name | EBURNAMENINE-14-CARBOXYLIC ACID, ETHYL ESTER, (3A,16A)- |
| EC Number | 256-028-0 |
| IUPAC Name | ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate |
| InChI | InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1 |
| InChI Key | DDNCQMVWWZOMLN-IRLDBZIGSA-N |
| MDL Number | MFCD00211233 |
| Molecular Formula | C22H26N2O2 |
| Molecular Weight | 350.4540 |
| NSC Number | 760093 |
| SMILES | O=C(OCC)C1=C[C@@](CCC2)(CC)[C@@](N2CC3)([H])C4=C3C5=CC=CC=C5N41 |
| UNII | 543512OBTC |
| Synonyms | Cavinton,
ethyl apovincaminate,
ethyl apovincaminate tartrate (1:1),
ethyl apovincaminate, (+-)-isomer,
ethyl apovincaminate, (16alpha)-isomer,
ethyl apovincaminate, (3alpha,16alpha)-isomer,
ethyl apovincaminate, 2-oxopentanedioate (1:1),
ethyl apovincaminate, 3H-labeled,
Kavinton,
RGH-4405,
TCV-3B,
vinpocetine,
vinpocetine,
42971-09-5,
Cavinton,
Ceractin,
Apovincaminic acid ethyl ester,
Ethyl apovincamin-22-oate,
TCV-3B,
Ethyl (+)-apovincaminate,
RGH-4405,
Vinpocetinum [INN-Latin],
cis-Apovincaminic acid ethyl ester,
RGH 4405,
(+)-Apovincaminic acid ethyl ester,
Ethyl (+)-cis-apovincaminate,
(+)-cis-Apovincaminic acid ethyl ester,
Apovincaminate d'ethyle [French],
AY 27,255,
Bravinton,
UNII-543512OBTC,
3-alpha,16-alpha-Apovincaminic acid ethyl ester,
Eburnamenine-14-carboxylic acid ethyl ester,
Ethyl apovincaminate,
EINECS 256-028-0,
BRN 0900803,
CHEMBL71752,
MLS000069635,
Ultra-Vinca,
543512OBTC,
MFCD00211233,
NCGC00018204-09,
Vinpocetinum,
SMR000058241,
Eburnamenine-14-carboxylic acid, ethyl ester, (3alpha,16alpha)-,
DSSTox_CID_3740,
TCV 3B,
DSSTox_RID_77176,
DSSTox_GSID_23740,
Apovincaminate d'ethyle,
C22H26N2O2,
Eburnamenine-14-carboxylic acid, ethyl ester, (3-alpha,16-alpha)-,
AY 27255,
(41S,13aS)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate,
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine, eburnamenine-14-carboxylic acid deriv.,
Vinpocetine [USAN:INN:JAN],
SR-01000075633,
Vinpocetin,
Vinpocetine (JAN/USAN/INN),
Vinpocetine-ethyl apovincaminate,
ethyl apovincaminate, (3alpha,16alpha)-isomer,
NCGC00016854-03,
vinpocetine-cavinton,
Vinpocetine [USAN:INN:BAN:JAN],
Prestwick_963,
CAS-42971-09-5,
Spectrum_001400,
Vinpocetine (Cavinton),
SpecPlus_000327,
AC1L9FGV,
Opera_ID_1325,
Prestwick0_000268,
Prestwick1_000268,
Prestwick2_000268,
Prestwick3_000268,
Spectrum2_001529,
Spectrum3_000961,
Spectrum4_001075,
Spectrum5_000966,
V 6383,
(3|A,16|A)-Eburnamenine-14-carboxylic acid ethyl ester,
Lopac0_001257,
SCHEMBL50081,
BSPBio_000116,
BSPBio_002561,
KBioGR_001430,
KBioSS_001880,
MLS001076294,
ARONIS24464,
DivK1c_006423,
SPECTRUM1503115,
Vinpocetine, >=98%, solid,
SPBio_001318,
SPBio_002335,
BPBio1_000128,
cid_443955,
GTPL5285,
Vinpocetine, analytical standard,
DTXSID5023740,
REGID_for_CID_443955,
CHEBI:32297,
KBio1_001367,
KBio2_001880,
KBio2_004448,
KBio2_007016,
KBio3_001781,
DDNCQMVWWZOMLN-IRLDBZIGSA-N,
HMS1568F18,
HMS1922G05,
HMS2090J22,
HMS2092L06,
HMS2095F18,
HMS3263L16,
HMS3402D12,
HMS3675H11,
HMS3712F18,
Pharmakon1600-01503115,
(3alpha, 16alpha)-Eburnamenine-14-carboxylic acid ethyl ester,
BCP04123,
Tox21_110648,
Tox21_110839,
Tox21_501257,
BDBM50059033,
CCG-39307,
NSC760093,
PD-185,
s2110,
ZINC19796031,
AKOS015896480,
Tox21_110648_1,
3A,16A-Apovincaminic acid ethyl ester,
CS-0545,
DB12131,
LP01257,
NSC-760093,
RP18037,
Vinpocetine 1.0 mg/ml in Acetonitrile,
(3S,16S)-apovincaminic acid ethylester,
NCGC00018204-05,
NCGC00018204-06,
NCGC00018204-07,
NCGC00018204-08,
NCGC00018204-10,
NCGC00018204-11,
NCGC00018204-13,
NCGC00021727-04,
NCGC00021727-05,
NCGC00021727-06,
NCGC00021727-07,
NCGC00168782-01,
NCGC00261942-01,
NCGC00263865-01,
AC-22612,
AS-13868,
AY-27255,
CC-35596,
HY-13295,
LS-63711,
SC-18612,
ST056350,
AB2000514,
AY-27,255,
Eburnamenine-14-carboxylic acid ethyl ester;,
EU-0101257,
D01371,
J10479,
W-5089,
AB00052317_02,
971V095,
C-20627,
SR-01000000118,
I06-1883,
SR-01000000118-3,
SR-01000075633-1,
SR-01000075633-3,
SR-01000075633-4,
W-202748,
BRD-K53318339-001-05-8,
(3?,16?)-Eburnamenine-14-carboxylic acid ethyl ester,
Vinpocetine, European Pharmacopoeia (EP) Reference Standard,
(3alpha,16alpha)-Eburnamenine-14-carboxylic acid ethyl ester,
Vinpocetine, United States Pharmacopeia (USP) Reference Standard,
(11aS,11bS)-11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester,
(3aS,11bS)-3a-ethyl-1,2,3,3a,10,11b-hexahydro-11H-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic acid ethyl ester,
11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid 2-nitrooxy-ethyl ester(Vinpocetine),
ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate,
ethyl (41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate,
Kavinton,
Vinporal,
Vinpocetine 20mg,
Intelectol (TN),
Cavinton (TN),
D06BCB,
ethyl apovincaminate tartrate,
Ethyl(+)-cis-apovincaminate,
V6383_SIGMA,
ethyl apovincaminate, 3H-labeled,
ethyl apovincaminate, (+-)-isomer,
CID443955,
ethyl apovincaminate tartrate (1:1),
C22-H26-N2-O2,
ACN-036654,
CS-O-02572,
ethyl apovincaminate, (16alpha)-isomer,
V0115,
ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate,
ethyl apovincaminate, 2-oxopentanedioate (1:1),
C013983,
(3-alpha,16-alpha)-Eburnamenine-14-carboxylic acid ethyl ester,
eburnamenine-14-carboxylic acid, ethyl ester, (3 alpha,16 alpha)-,
Vinpocetine, 98%, a selective inhibitor for PDE1 - 100mg 100mg,
Eburnamenine-14-carboxylic acid, ethyl ester, (3.alpha.,16.alpha.)-,
42971-12-0,
Ethyl (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate,
|
| Complexity | 617 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 350.199g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 350.462g/mol |
| Monoisotopic Mass | 350.199g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 34.5A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 4.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

